Related Experiment Videos
GSTM1 polymorphism and oral leukoplakia
Eliza Carla Barroso Duarte1, Marina Sena Lopes da Silva, Marcus Vinícius Gomez
1Department of Oral Pathology and Surgery, School of Dentistry, Universidade Federal de of Minas Gerais, Belo Horizonte, Brazil.
Summary
The GSTM1 null genotype, a genetic variation, significantly increases the risk of developing oral leukoplakia in tobacco smokers. This finding highlights the role of genetic susceptibility in oral cancer development.
Area of Science:
- Genetics
- Molecular Epidemiology
- Oncology
Background:
- Individual cancer susceptibility is influenced by genetic and environmental factors, particularly in relation to tobacco carcinogen metabolism.
- Genetic polymorphisms in enzymes affect the activation or deactivation of carcinogens, thereby influencing cancer risk.
Purpose of the Study:
- To investigate the association between the GSTM1 null polymorphism and the risk of oral leukoplakia in Brazilian tobacco smokers.
Main Methods:
- A case-control study involving 52 tobacco-smoking patients with oral leukoplakia and 52 tobacco-smoking controls from Brazil.
- GSTM1 genotypes were determined using polymerase chain reaction (PCR)-based methods.
Main Results:
- The GSTM1 null genotype was significantly more frequent in oral leukoplakia patients (57.7%) compared to controls (34.6%), indicating a 2.57-fold increased risk (OR: 2.57, 95% CI: 1.16-5.69).
- Among lesions with moderate/severe dysplasia, the prevalence of the GSTM1 null genotype was higher (68.2%) than in controls (31.9%), showing a 4.59-fold increased risk (OR: 4.59, 95% CI: 1.29-16.33).
Conclusions:
- The GSTM1 null genotype is associated with an increased risk of oral leukoplakia development.
- This genetic factor may play a significant role in the pathogenesis of oral lesions among tobacco users.